Senior Director, Clinical Lead - Neurodegeneration
Johnson & Johnson UK
Cambridge, Massachusetts, United States of America
Base: $226,000 to $391,000 usd; bonus/equity: elig...
Clinical leader in neurodegeneration
Late phase drug development
Execution of clinical strategy
The incumbent will serve as a Clinical Leader in Neurodegeneration, Neuroscience, with a focus on innovative late phase drug development for Alzheimer’s Disease projects
Job Summary
The incumbent will serve as a Clinical Leader in Neurodegeneration, Neuroscience, with a focus on innovative late phase drug development for Alzheimer’s Disease projects.
Lead the clinical team and be responsible for timely completion, content and quality of key documents e.g. clinical development plans, protocol development, execution of clinical studies, preparation of clinical study reports and for the preparation and approval of essential documents for regulatory filings.
Builds professional relationships with opinion leaders, investigators and key regulatory officials.
Matching Summary
The incumbent will serve as a Clinical Leader in Neurodegeneration, Neuroscience, with a focus on innovative late phase drug development for Alzheimer’s Disease projects.
Salary
Base: $226,000 to $391,000 USD; Bonus/Equity: Eligible for long-term incentive program; Benefits: Medical, dental, vision, life insurance, disability, retirement plan, 401(k), paid time off
Skills & Requirements
Must-have
Clinical Leader in Neurodegeneration
late phase drug development
execution of clinical strategy
cross functional clinical team leader
Alzheimer’s Disease projects
Nice-to-have
innovative clinical trial design
strong relationships and influence
problem-solving and conflict resolution
building professional relationships with opinion leaders
company spokesperson regarding research findings
Key Requirements
MD (or equivalent) required
10 years of experience in clinical research
Board certification in neurology or psychiatry required